Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:03:57.902Z.
Calculation as of: 2026-10-06T16:03:57.902Z.
Quote observation: 2026-10-06T16:00:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47811cd6fce140e68777d2609bf88a35ade871fb75fdb0cf4ca3c33c868081b2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Medicus Pharma Ltd. Common Stock
Market Cap
$10.06M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.06M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.68M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.52M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.55M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.68M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.34M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
